Nanobiotix S.A. (NBTX) stock
NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
$27.45−1.09 (-3.82%)
Close on Nov 17, 2026Market cap $1.33BP/E –Yield –
Nanobiotix cash
Cash and short-term investments held at the end of each period.
Nanobiotix's cash was €110.89M at Jun 30, 2026. For fiscal 2025 it was €52.75M, up 6.1% from the year before. The highest annual figure on record is €119.15M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €52.75M | +6.1% |
| FY2024 | Dec 31, 2024 | €49.74M | -33.9% |
| FY2023 | Dec 31, 2023 | €75.28M | +81.9% |
| FY2022 | Dec 31, 2022 | €41.39M | -50.7% |
| FY2021 | Dec 31, 2021 | €83.92M | -29.6% |
| FY2020 | Dec 31, 2020 | €119.15M | +239.5% |
| FY2019 | Dec 31, 2019 | €35.09M | -3.1% |
| FY2018 | Dec 31, 2018 | €36.20M | -23.3% |
| FY2017 | Dec 31, 2017 | €47.21M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | €110.89M | +67.2% |
| Q4 FY2025 | Dec 31, 2025 | €52.75M | -29.9% |
| Q2 FY2025 | Jun 30, 2025 | €28.82M | +33.2% |
| Q4 FY2024 | Dec 31, 2024 | €49.74M | +20.2% |
| Q2 FY2024 | Jun 30, 2024 | €66.34M | +5.3% |
| Q4 FY2023 | Dec 31, 2023 | €75.28M | -10.3% |
| Q2 FY2023 | Jun 30, 2023 | €21.63M | -78.9% |
| Q4 FY2022 | Dec 31, 2022 | €41.39M | -65.3% |
| Q2 FY2022 | Jun 30, 2022 | €63.02M | +137.0% |
| Q4 FY2021 | Dec 31, 2021 | €83.92M | +139.1% |
| Q2 FY2021 | Jun 30, 2021 | €102.34M | +182.7% |
| Q4 FY2020 | Dec 31, 2020 | €119.15M | +152.4% |
| Q2 FY2020 | Jun 30, 2020 | €26.59M | – |
| Q4 FY2019 | Dec 31, 2019 | €35.09M | – |
| Q4 FY2018 | Dec 31, 2018 | €36.20M | – |
| Q4 FY2017 | Dec 31, 2017 | €47.21M | – |
See a number that looks wrong?